Prestige Consumer Healthcare, Inc. (PBH)
52.30
+1.09
(+2.13%)
USD |
NYSE |
Aug 28, 15:37
Prestige Consumer Healthcare Cash from Operations (Quarterly) : 70.79M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 70.79M |
| March 31, 2026 | 42.84M |
| December 31, 2025 | 78.29M |
| September 30, 2025 | 57.49M |
| June 30, 2025 | 79.01M |
| March 31, 2025 | 61.85M |
| December 31, 2024 | 65.09M |
| September 30, 2024 | 69.80M |
| June 30, 2024 | 54.78M |
| March 31, 2024 | 66.91M |
| December 31, 2023 | 71.47M |
| September 30, 2023 | 62.46M |
| June 30, 2023 | 48.09M |
| March 31, 2023 | 58.99M |
| December 31, 2022 | 54.94M |
| September 30, 2022 | 57.54M |
| June 30, 2022 | 58.25M |
| March 31, 2022 | 63.13M |
| December 31, 2021 | 66.30M |
| September 30, 2021 | 61.19M |
| June 30, 2021 | 69.30M |
| March 31, 2021 | 59.09M |
| December 31, 2020 | 49.23M |
| September 30, 2020 | 52.14M |
| June 30, 2020 | 75.15M |
| Date | Value |
|---|---|
| March 31, 2020 | 56.13M |
| December 31, 2019 | 58.00M |
| September 30, 2019 | 50.22M |
| June 30, 2019 | 52.78M |
| March 31, 2019 | 50.85M |
| December 31, 2018 | 43.33M |
| September 30, 2018 | 39.26M |
| June 30, 2018 | 55.85M |
| March 31, 2018 | 54.44M |
| December 31, 2017 | 47.13M |
| September 30, 2017 | 54.42M |
| June 30, 2017 | 54.12M |
| March 31, 2017 | 7.424M |
| December 31, 2016 | 40.07M |
| September 30, 2016 | 49.54M |
| June 30, 2016 | 50.74M |
| March 31, 2016 | 37.90M |
| December 31, 2015 | 45.86M |
| September 30, 2015 | 47.07M |
| June 30, 2015 | 43.52M |
| March 31, 2015 | 52.11M |
| December 31, 2014 | 47.08M |
| September 30, 2014 | 27.39M |
| June 30, 2014 | 29.67M |
| March 31, 2014 | 30.72M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 228.52M |
| ANI Pharmaceuticals, Inc. | 56.67M |
| Corcept Therapeutics, Inc. | 33.54M |
| Veru, Inc. | -5.467M |
| Johnson & Johnson | 8.616B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.064B |
| Cash from Financing (Quarterly) | 1.018B |
| Free Cash Flow | 235.36M |
| Free Cash Flow Per Share (Quarterly) | 1.409 |
| Free Cash Flow to Equity (Quarterly) | -954.92M |
| Free Cash Flow to Firm (Quarterly) | 77.64M |
| Free Cash Flow Yield | 9.34% |